Literature DB >> 8985205

Interaction with autologous platelets multiplies interleukin-1 and tumor necrosis factor production in mononuclear cells.

K Aiura1, B D Clark, C A Dinarello, N H Margolis, G Kaplanski, J F Burke, R G Tompkins, J A Gelfand.   

Abstract

The effect of activated platelets on cytokine production by human peripheral blood mononuclear cells (PBMC) was investigated. When PBMC were coincubated with activated autologous platelets amid lipopolysaccharide (LPS, 50-100 pg/mL) for 8 h, the production of interleukin (IL)-1alpha increased 11- to 18-fold and tumor necrosis factor (TNF)-alpha 3- to 5-fold compared with PBMC without platelets. Activated platelets in a dual-chamber well that prevented platelet-PBMC contact but permitted passage of soluble factors enhanced IL-1alpha production (P < .01). Platelet-PBMC contact in the chamber resulted in a further enhancement of IL-1alpha production. These data suggest that platelet-PBMC interaction, both directly and with platelet-derived factors, enhances production of shock-producing IL-1alpha and TNF-alpha, albeit differently. The interaction of platelets with monocytes may play an important role in the pathophysiology of sepsis and disseminated intravascular coagulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985205     DOI: 10.1093/infdis/175.1.123

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

1.  Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway.

Authors:  Binggang Xiang; Guoying Zhang; Ling Guo; Xiang-An Li; Andrew J Morris; Alan Daugherty; Sidney W Whiteheart; Susan S Smyth; Zhenyu Li
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

2.  Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice.

Authors:  Sacha F de Stoppelaar; Cornelis van 't Veer; Theodora A M Claushuis; Bregje J A Albersen; Joris J T H Roelofs; Tom van der Poll
Journal:  Blood       Date:  2014-10-09       Impact factor: 22.113

Review 3.  Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?

Authors:  Laís Teodoro da Silva; Bruna Tereso Santillo; Alexandre de Almeida; Alberto Jose da Silva Duarte; Telma Miyuki Oshiro
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

4.  Monocytes complexed to platelets differentiate into functionally deficient dendritic cells.

Authors:  Meera V Singh; Sumanun Suwunnakorn; Sydney R Simpson; Emily A Weber; Vir B Singh; Pawel Kalinski; Sanjay B Maggirwar
Journal:  J Leukoc Biol       Date:  2020-07-14       Impact factor: 4.962

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.